Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
General Genetics Corporation
With
Syntactx
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subject underwent PGx testing for the alleles appropriate to the target drugs within the prior 90 days ('index PGx test')
Males and females aged ≥65 years or male and females aged ≥18 years who have a disability
Subject is able and willing to provide written informed consent
Subject was receiving at least one medication known to be associated with allelic variation at the time of the index PGx test, including over-the-counter medications
Subject has a history of at least one target drug-related adverse event (TDAE) over the 12-month period preceding receipt of PGx test results, or has experienced inadequate efficacy from a target drug
You may not be if
Subject is currently hospitalized
Subject's medical and medication history is unavailable over the 90-day period preceding the receipt of PGx test results
Subject is unable to provide an accurate history due to mental incapacity
Subject is known to have undergone prior PGx testing for genes specific to the target drug(s), exclusive of the PGx test relating to this Registry
Clareo Health | Pharmacogenomic Testing Of the Elderly To Reduce Morbidity
